Sotera Health Company (NASDAQ:SHC) Given Consensus Rating of "Moderate Buy" by Analysts

Key Points

• Analysts assign Sotera Health a consensus rating of "Moderate Buy" from 11 brokers, with an average 12‑month price target of $20.14, implying upside from the recent share price (~$15.81).
• A director, GTCR Investment, sold 10,000,000 shares for $152.7M—reducing its stake by about 43.98%—while hedge funds and other institutions now own roughly 91.03% of the stock.
• Sotera beat quarterly estimates (EPS $0.26 vs. $0.24; revenue $303.44M vs. $300.68M) and set FY2026 guidance of $0.93–1.01 EPS, above the average analyst forecast of $0.88.

Sotera Health Company (NASDAQ:SHC - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eleven brokerages that are presently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $20.1429.

Several equities research analysts recently commented on the company. Barclays cut their target price on Sotera Health from $20.00 to $18.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 14th. Royal Bank Of Canada initiated coverage on Sotera Health in a report on Thursday, January 8th. They issued an "outperform" rating and a $24.00 target price on the stock. Zacks Research downgraded Sotera Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, January 30th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Sotera Health in a research report on Monday, December 29th. Finally, Wall Street Zen downgraded Sotera Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, April 11th.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm's stock in a transaction on Friday, March 6th. The stock was sold at an average price of $15.27, for a total value of $152,700,000.00. Following the completion of the sale, the director directly owned 12,735,301 shares of the company's stock, valued at $194,468,046.27. This trade represents a 43.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 15.36% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Sotera Health

Several hedge funds have recently made changes to their positions in the stock. Sculptor Capital LP boosted its stake in Sotera Health by 57.4% during the fourth quarter. Sculptor Capital LP now owns 21,000,000 shares of the company's stock valued at $370,440,000 after buying an additional 7,658,200 shares during the period. Vanguard Group Inc. lifted its stake in Sotera Health by 16.7% during the fourth quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company's stock worth $339,189,000 after purchasing an additional 2,756,583 shares during the last quarter. Sachem Head Capital Management LP increased its holdings in shares of Sotera Health by 47.2% in the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company's stock worth $205,418,000 after buying an additional 3,735,000 shares during the period. Janus Henderson Group PLC increased its holdings in shares of Sotera Health by 4.8% in the fourth quarter. Janus Henderson Group PLC now owns 6,772,059 shares of the company's stock worth $119,460,000 after buying an additional 312,191 shares during the period. Finally, State Street Corp increased its holdings in shares of Sotera Health by 21.0% in the fourth quarter. State Street Corp now owns 5,965,326 shares of the company's stock worth $105,228,000 after buying an additional 1,035,457 shares during the period. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Sotera Health Trading Up 1.5%

Shares of SHC stock opened at $15.81 on Tuesday. Sotera Health has a 1-year low of $10.68 and a 1-year high of $19.85. The company has a current ratio of 2.46, a quick ratio of 2.24 and a debt-to-equity ratio of 3.66. The stock has a 50-day moving average of $15.15 and a 200-day moving average of $16.50. The stock has a market cap of $4.51 billion, a price-to-earnings ratio of 58.56 and a beta of 1.88.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its earnings results on Tuesday, February 24th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The company had revenue of $303.44 million for the quarter, compared to analyst estimates of $300.68 million. During the same quarter in the prior year, the company earned $0.21 EPS. The firm's revenue for the quarter was up 4.6% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. On average, equities research analysts forecast that Sotera Health will post 0.88 earnings per share for the current year.

About Sotera Health

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.